C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education